Your SlideShare is downloading. ×

Adult and Adolescent Vaccines Market to 2018 Available on Researchmoz.us

81

Published on

Adult and Adolescent Vaccines Market to 2018. The report provides insights into the vaccines in the adult and adolescent vaccines market, including market forecasts up to 2018. It provides an in-depth …

Adult and Adolescent Vaccines Market to 2018. The report provides insights into the vaccines in the adult and adolescent vaccines market, including market forecasts up to 2018. It provides an in-depth analysis of the vaccines for the adult and adolescent market, as well as insights into the adult and adolescent vaccines market’s Research and Development (R&D) pipeline. The report provides in-depth analysis of the unmet needs, drivers and barriers that affect the global adult and adolescent vaccines market.

Published in: Health & Medicine, Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
81
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
2
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development andPrevnar Approval for Use in Adults to Drive Growth Adult and Adolescent Vaccines Market to 2018. The report provides insights into the vaccines in the adultand adolescent vaccines market, including market forecasts up to 2018. It provides an in-depth analysis of thevaccines for the adult and adolescent market, as well as insights into the adult and adolescent vaccinesmarket’s Research and Development (R&D) pipeline. The report provides in-depth analysis of theunmet needs, drivers and barriers that affect the global adult and adolescent vaccines market. The reportanalyzes the market for adult and adolescent vaccines in the US, and the top five countries in Europe (the UK,Germany, France, Italy and Spain) and Japan. The report discusses the global pipeline for adult and adolescentvaccines across various stages of development. The report is built using data and information sourced fromproprietary databases, primary and secondary research and in-house analysis by GBI Research’s teamof industry experts. GBI Research found that the adult and adolescent vaccines market in the top sevenmarkets was valued at $7.2 billion in 2011, increasing at a Compound Annual Growth Rate (CAGR) of 6.9%during the 2007–2011 historic period. The market is projected to witness a growth of 5.6% during the2011–2018 forecast period to reach $10.5 billion. The growth in the adult and adolescent vaccinesmarket is driven by increased uptake of pneumococcal vaccines such as Prevnar 13 which got approved foruse in people aged 50 and older. The pneumococcal vaccines market is expected to grow at a CAGR of 19%during the forecast period and reach $1.7 billion in 2018, from $0.5 billion in 2011. Scope Annualized market data for the adult and adolescent vaccines market from 2007 to 2011, forecast forward to2018 Analysis of the adult and adolescent vaccines market in the leading geographies of the world, whichincludes the US, the UK, Germany, France, Italy, Spain, and Japan Market characterization of the adult andadolescent vaccines market including market size and cost of vaccination Key drivers and barriers that have asignificant impact on the market Coverage of pipeline molecules in various phases of vaccine developmentCompetitive benchmarking of leading companies. Key companies studied in this report are GlaxoSmithKline,Sanofi, Pfizer, Merck and Novartis. Key M&A activities and licensing agreements that have taken placebetween 2009 and up to November 2012 in the global adult and adolescent vaccines market. Reasons to Buy Align your product portfolio to the markets with the highest growth potential Develop market-entry andmarket expansion strategies by identifying the potential regions and adult and adolescent vaccines marketsegments poised for strong growth Create a more specifically-tailored country strategy through theunderstanding of key drivers and barriers of the global adult and adolescent vaccines market Develop keystrategic initiatives by understanding the key focus areas and top-selling products of leading companiesAccelerate and strengthen your market position by identifying key companies for mergers, acquisitions andstrategic partnerships.table Of ContentsAdult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in A
  • 2. 1 Table Of Contents1.1 List Of Tables1.2 List Of Figures2 Adult And Adolescent Vaccines Market To 2018: Introduction2.1 Overview3 Adult And Adolescent Vaccines Market To 2018: Overview3.1 Vaccine Preventable Diseases3.1.1 Types Of Vaccines3.2 Recommendations For Immunization3.2.1 The Us3.2.2 Top Five European Countries3.2.3 Japan3.3 Regulatory Framework3.3.1 The Us3.3.2 Top Five European Countries3.3.3 Japan3.4 Vaccine Manufacturing Process4 Adult And Adolescent Vaccines Market To 2018: Market Characterization And Forecast4.1 Revenue Forecast4.2 Market Share By Type Of Vaccines4.3 Market Share By Geography4.4 Drivers4.4.1 Adult Vaccines Segment To Drive Future Growth4.4.2 High Unmet Needs4.4.3 Targeting New Diseases Areas For Vaccines Likely To Drive The Market4.4.4 Novel Vaccine Technologies4.5 Restraints4.5.1 Production Capacity Limitations4.5.2 High Initial Capital Investments And Technical Expertise4.5.3 Regulations Delay Vaccine Launch And Acceptance5 Adult And Adolescent Vaccines Market To 2018: Influenza Vaccines 5.1 Disease Overview 5.2 Market Forecasts 5.2.1 The Us 5.2.2 Top Five European Countries 5.2.3 JapanAdult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in A
  • 3. 5.3 Cost Of Vaccination5.3.1 The Us5.3.2 Top Five European Countries5.3.3 Japan5.4 Pipeline Analysis – Influenza Vaccines6 Adult And Adolescent Vaccines Market To 2018: Tetanus, Diphtheria And Pertussis Vaccines6.1 Disease Overview6.2 Market Forecasts6.2.1 The Us6.2.2 Top Five European Countries6.2.3 Japan6.3 Cost Of Vaccination6.3.1 The Us6.3.2 Top Five European Countries6.3.3 Japan6.4 Pipeline Analysis – Tetanus, Diphtheria, Pertussis (td/tdap) Vaccines7 Adult And Adolescent Vaccines Market To 2018: Pneumococcal Vaccines7.1 Disease Overview7.2 Market Forecasts7.2.1 The Us7.2.2 Top Five European Countries7.2.3 Japan7.3 Cost Of Vaccination7.3.1 The Us7.3.2 Top Five European Countries7.3.3 Japan7.4 Pipeline Analysis – Pneumococcal Vaccines8 Adult And Adolescent Vaccines Market To 2018: Meningococcal Vaccines8.1 Disease Overview8.2 Market Forecasts8.2.1 The Us8.2.2 Top Five European Countries8.3 Cost Of Vaccination8.3.1 The Us8.3.2 Top Five European Countries8.4 Pipeline Analysis – Meningococcal VaccinesAdult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in A
  • 4. 9 Adult And Adolescent Vaccines Market To 2018: Human Papilloma Virus Vaccines9.1 Disease Overview9.2 Market Forecasts9.2.1 The Us9.2.2 Top Five European Countries9.2.3 Japan9.3 Cost Of Vaccination9.3.1 The Us9.3.2 Top Five European Countries9.3.3 Japan9.4 Pipeline Analysis – Human Papillomavirus Vaccines10 Adult And Adolescent Vaccines Market To 2018: Hepatitis Vaccines10.1 Disease Overview10.2 Market Forecasts10.2.1 The Us10.2.2 Top Five European Countries10.2.3 Japan10.3 Cost Of Vaccination10.3.1 The Us10.3.2 Top Five European Countries10.3.3 Japan10.4 Pipeline Analysis – Hepatitis Vaccines11 Adult And Adolescent Vaccines Market To 2018: Measles, Mumps And Rubella Vaccines11.1 Disease Overview11.2 Market Forecasts11.2.1 The Us11.2.2 Top Five European Countries11.2.3 Japan11.3 Cost Of Vaccination11.3.1 The Us11.3.2 Top Five European Countries11.3.3 Japan12 Adult And Adolescent Vaccines Market To 2018: Zoster Vaccines12.1 Disease Overview12.2 Market Forecasts12.2.1 The Us12.2.2 The UkAdult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in A
  • 5. 12.3 Cost Of Vaccination12.3.1 The Us12.3.2 The Uk12.4 Pipeline Analysis – Zoster Vaccines13 Adult And Adolescent Vaccines Market To 2018: Varicella Vaccines13.1 Disease Overview13.2 Market Forecasts13.2.1 The Us13.2.2 Top Five European Countries13.2.3 Japan13.3 Cost Of Vaccination13.3.1 The Us13.3.2 Top Five European Countries13.3.3 Japan13.4 Pipeline Analysis – Varicella Vaccines14 Adult And Adolescent Vaccines Market To 2018: Competitive Landscape14.1 Introduction14.2 Major Company Profiles14.2.1 Glaxosmithkline14.2.2 Sanofi14.2.3 Pfizer14.2.4 Merck14.2.5 Novartis15 Adult And Adolescent Vaccines Market To 2018: Strategic Consolidations15.1 Deals By Year15.2 Deals By Type15.3 Deals By Value15.4 Deals By Geography15.5 Summary Of Major M&a Deals15.6 Summary Of Major Licensing Deals15.7 Summary Of Major Partnerships16 Adult And Adolescent Vaccines Market To 2018: Appendix16.1 Market Definitions16.2 Abbreviations16.3 BibliographyAdult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in A
  • 6. 16.4 Research Methodology16.4.1 Coverage16.4.2 Secondary Research16.4.3 Primary Research16.4.4 Model For Estimation Of Vaccine Market16.5 Geographical Landscape16.6 Pipeline Analysis16.7 Competitive Landscape16.7.1 Expert Panel Validation16.8 Contact Us16.9 DisclaimerAbout Us:Transparency Market Research is a market intelligence company providing global business informationreports and services. Our exclusive blend of quantitative forecasting and trends analysis providesforward-looking insight for thousands of decision makers. We are privileged with highly experienced team ofAnalysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques togather, and analyze information. Our business offerings represent the latest and the most reliable informationindispensable for businesses to sustain a competitive edge.Contact:ResearchMoz90 State Street,Suite 700,Albany NY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-997-4948Email: sales@researchmoz.usBlog: http://researchmoz.blogspot.com/Website: http://www.researchmoz.us/Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in A

×